Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has 277 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 206,291 | 3.21% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 131,087 | 1.29% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 496,295 | 50.97% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -145,749 | -28.87% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 610,559 | 16.54% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -226,856 | -15.56% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -17,527 | -22.80% | $0.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 0 | -4,048,828 | -50.47% | $0.00 |
| Russell Investments Group, Ltd. | 31 Dec, 2025 | 0 | 369 | 0.04% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 14,348 | 1,323.62% | $0.00 |
| SANDS CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -284,129 | -7.54% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 119,329 | 17.49% | $0.00 |
| Osbon Capital Management LLC | 31 Dec, 2025 | 0 | 86 | 0.00% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | -258,127 | -7.92% | $0.00 |
| Schonfeld Strategic Advisors LLC | 31 Dec, 2025 | 0 | -402,971 | -35.21% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 121,786 | 22.26% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -4,617,047 | -63.39% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | -27,082 | -4.64% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 516,781 | 26.57% | $0.00 |